welcome
TipRanks

TipRanks

Business

Business & Economics

Maravai Lifesciences price target lowered to $5 from $10 at Stifel

TipRanks
Summary
Nutrition label

81% Informative

Stifel lowered the firm’s price target on Maravai Lifesciences to $ 5 from $ 10 and keeps a Buy rating on the shares.

The firm notes Q4 revenues came up $1M light of the Street, while EBITDA fell short by $7M.

The transition from COVID to non-COVID demand, the China uncertainty, and the opaqueness of key model area make for a low visibility situation.

VR Score

75

Informative language

68

Neutral language

79

Article tone

formal

Language

English

Language complexity

47

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

Affiliate links

no affiliate links

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.